TCR2 THERAPEUTICS INC. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q2 2021 to Q3 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Tcr2 Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q2 2021 to Q3 2022.
- Tcr2 Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending September 30, 2022 was $4.33M, a 17.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)